Biochips are miniaturized
laboratories that can perform thousands of biochemical reactions such as polymerase
chain reaction (PCR) simultaneously and are used for a variety of purposes
ranging from disease diagnosis to detection of bioterrorism agents. This report
estimates the U.S. market for biochips in terms of revenue (USD million) for
the period 2012 to 2018, considering 2011 as the base year.
The biochip market is segmented
into products market and services market. The biochip market by products is
sub-segmented into three types, namely, microarrays, reagents and other
products including biochip instruments and software. The biochip products and
services market by application is sub-segmented into drug discovery, life
science research, IVD testing and other applications including disease
management, forensic medicines, drug-of-abuse testing and military and defense
applications.
The report provides an analysis
of market dynamics, which includes drivers, restraints and opportunities for
the biochip market in the U.S. It also analyses the internal and external
market factors and their effect on the ecosystem of the biochip market, with
the help of Porter’s five force analysis.
The report includes company
profiles of key market players such as Affymetrix, Inc., Life Technologies
Corporation, Illumina, Inc. and others. Profiles for all market players have
been provided based on parameters such as company overview, financial overview,
product portfolio, business strategies and recent developments.
The U.S. biochip market is
categorized into the following segments:
Biochip Market, by
Segments
Biochip Products Market
Biochip Services Market
Biochip Products
Market, by Types
Microarrays
Reagents and Other Consumables
Others (Biochip Instruments and
Software)
Biochip Market, by
Applications
Drug Delivery
Life Science Research
In Vitro Diagnostic Testing
Others (Disease Management,
Forensic Medicine, Defense)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Rise in the Application
Of Genomics And Proteomics Technologies In Cancer Research
3.1.1.2 Growth In Drug Discovery, Personalized
Medicine And Life Science Research
3.1.1.3 Impact Analysis Of
Market Drivers
3.1.2 Market Restraints
3.1.2.1 Low Commercial
Acceptability Of Biochips Due To Their High Cost
3.1.2.2 Availability Of
Alternative Technologies Such As Mass Spectrometry And Polymerase Chain
Reaction (PCR)
3.1.2.3 Impact Analysis Of
Market Restraints
3.1.3 Opportunities
3.1.3.1 New Applications Of
Biochips
3.2 Porter’s Five Force
Analysis For The U.S. Biochip Market
3.2.1 Bargaining Power Of Suppliers
3.2.2 Bargaining Power Of Buyers
3.2.3 Threat Of New Entrants
3.2.4 Threat Of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness
Analysis Of The U.S. Biochip Market, By Product Type
3.4 Market Size And Trends
3.4.1 U.S. Biochip Market, 2011 – 2018
(USD Million)
Browse All Market Research Report : http://www.transparencymarketresearch.com/
0 comments:
Post a Comment
Note: only a member of this blog may post a comment.